Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of RO7837195 in participants with moderately to severely active Ulcerative Colitis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• RO7837195

Snippet

Sponsor: Genentech, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING